All news

HealthEquity rated Moderate Buy by Wall Street analysts

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

HealthEquity (NASDAQ:HQY) carries a "Moderate Buy" consensus from Wall Street analysts, with an average 12-month price target of

Read original source

HQY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.